These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 19952302)

  • 21. Promising new approaches.
    Reasner CA
    Diabetes Obes Metab; 1999 May; 1 Suppl 1():S41-8. PubMed ID: 11220287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Replacing SUs with incretin-based therapies for type 2 diabetes mellitus: challenges and feasibility.
    Knop FK; Holst JJ; Vilsbøll T
    IDrugs; 2008 Jul; 11(7):497-501. PubMed ID: 18600596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beta-cell function and mass in type 2 diabetes.
    Larsen MO
    Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Beyond glycemic control in type 2 diabetes. Promises and gambles of therapy with glucagon-like peptide-1 receptor agonists].
    Mannucci E
    G Ital Cardiol (Rome); 2011 Dec; 12(12 Suppl 2):3-4. PubMed ID: 22158420
    [No Abstract]   [Full Text] [Related]  

  • 25. An overview of incretin clinical trials.
    Garber AJ; Spann SJ
    J Fam Pract; 2008 Sep; 57(9 Suppl):S10-8. PubMed ID: 18786339
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incretin mimetics and DPP-IV inhibitors for the treatment of type 2 diabetes.
    Nielsen LL
    Drug Discov Today; 2005 May; 10(10):703-10. PubMed ID: 15896683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic approach of type 2 diabetes mellitus with GLP-1 based therapies.
    Penfornis A; Borot S; Raccah D
    Diabetes Metab; 2008 Feb; 34 Suppl 2():S78-90. PubMed ID: 18640590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incretins and other peptides in the treatment of diabetes.
    Todd JF; Bloom SR
    Diabet Med; 2007 Mar; 24(3):223-32. PubMed ID: 17263764
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of weight gain on outcomes in type 2 diabetes.
    Ross SA; Dzida G; Vora J; Khunti K; Kaiser M; Ligthelm RJ
    Curr Med Res Opin; 2011 Jul; 27(7):1431-8. PubMed ID: 21599553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluating treatment algorithms for the management of patients with type 2 diabetes mellitus: a perspective on the definition of treatment success.
    Aguilar RB
    Clin Ther; 2011 Apr; 33(4):408-24. PubMed ID: 21635988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Multifactorial Approach to Reduce Cardiovascular Disease in Type 2 Diabetes Mellitus: Now More Than Ever.
    Basile JN
    Hosp Pract (1995); 2016; 44(1):9-20. PubMed ID: 26781810
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-insulin treatments for diabetes.
    Angueira E
    Am J Ther; 2013; 20(4):377-84. PubMed ID: 23838634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effects of incretin on cardiovascular disease and risk factors].
    Kodama K; Node K
    Nihon Rinsho; 2011 May; 69(5):836-41. PubMed ID: 21595268
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comprehensive diabetes cardiovascular treatment = sugar + blood pressure + lipids.
    Bloomgarden Z; Handelsman Y; Einhorn D
    J Diabetes; 2011 Dec; 3(4):257-60. PubMed ID: 21951572
    [No Abstract]   [Full Text] [Related]  

  • 35. Weight-centric pharmacological management of type 2 diabetes mellitus - An essential component of cardiovascular disease prevention.
    Muzurović E; Dragnić S; Medenica S; Smolović B; Bulajić P; Mikhailidis DP
    J Diabetes Complications; 2020 Aug; 34(8):107619. PubMed ID: 32499116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comprehensive treatment for type 2 diabetes mellitus.
    Min R; Li YX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2011 Jun; 33(3):257-61. PubMed ID: 21718606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phytochemicals targeting genes relevant for type 2 diabetes.
    Anuradha CV
    Can J Physiol Pharmacol; 2013 Jun; 91(6):397-411. PubMed ID: 23745945
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological Intervention in Type 2 Diabetes Mellitus - A Pathophysiologically Reasoned Approach?
    Forst T; Heise T; Plum-Morschel L
    Curr Diabetes Rev; 2016; 12(4):429-439. PubMed ID: 27296043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Weight and type 2 diabetes: new recommendations.
    Gómez Huelgas R
    Med Clin (Barc); 2016 Nov; 147 Suppl 1():17-21. PubMed ID: 28760220
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Opportunities to improve risk factor control in type 2 diabetes and reduce cardiovascular events.
    Cardiovasc J S Afr; 2005; 16(5):283-4. PubMed ID: 16307163
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.